ArticleOncology letters2018

Histone deacetylase inhibitors sensitize 5-fluorouracil-resistant MDA-MB-468 breast cancer cells to 5-fluorouracil.

Tetsuya Minegaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.